Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 326

Related Citations for PubMed (Select 17512987)

1.

Neuromyelitis optica: changing concepts.

Jacob A, Matiello M, Wingerchuk DM, Lucchinetti CF, Pittock SJ, Weinshenker BG.

J Neuroimmunol. 2007 Jul;187(1-2):126-38. Epub 2007 May 21. Review.

PMID:
17512987
2.

Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.

Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, Varrin-Doyer M, Cavillon G, Rogemond V, Confavreux C, Honnorat J, Giraudon P.

Brain. 2010 Sep;133(9):2578-91. doi: 10.1093/brain/awq177. Epub 2010 Aug 5.

3.

Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.

Chan KH, Ramsden DB, Yu YL, Kwok KH, Chu AC, Ho PW, Kwan JS, Lee R, Lim E, Kung MH, Ho SL.

Eur J Neurol. 2009 Mar;16(3):310-6. doi: 10.1111/j.1468-1331.2008.02376.x.

PMID:
19138340
4.

Neuromyelitis optica: a new perspective.

Pittock SJ.

Semin Neurol. 2008 Feb;28(1):95-104. doi: 10.1055/s-2007-1019131. Review.

PMID:
18256990
5.

[Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].

Jordan B, Eger K, Kornhuber ME, Zierz S.

Fortschr Neurol Psychiatr. 2008 Jan;76(1):21-7. doi: 10.1055/s-2007-993032. Review. German.

PMID:
18189220
6.

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.

Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA.

Neurology. 2007 Dec 11;69(24):2221-31. Epub 2007 Oct 10.

PMID:
17928579
7.

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B.

Nat Clin Pract Neurol. 2008 Apr;4(4):202-14. doi: 10.1038/ncpneuro0764. Epub 2008 Mar 11. Review.

PMID:
18334978
8.

Neuromyelitis optica.

Wingerchuk DM.

Int MS J. 2006 May;13(2):42-50. Review.

PMID:
16635421
9.

Devic's neuromyelitis optica: a critical review.

Lana-Peixoto MA.

Arq Neuropsiquiatr. 2008 Mar;66(1):120-38. Review.

10.

The spectrum of neuromyelitis optica.

Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG.

Lancet Neurol. 2007 Sep;6(9):805-15. Review.

PMID:
17706564
11.

Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity.

Saini H, Fernandez G, Kerr D, Levy M.

J Neuroimmunol. 2010 Apr 15;221(1-2):68-72. doi: 10.1016/j.jneuroim.2010.02.007. Epub 2010 Mar 15.

PMID:
20227773
12.

[Neuromyelitis optica: a clinical update].

Chiquete E, Navarro-Bonnet J, Ayala-Armas R, Gutiérrez-Gutiérrez N, Solórzano-Meléndez A, Rodríguez-Tapia D, Gómez-Rincón M, Ruiz-Sandoval JL.

Rev Neurol. 2010 Sep 1;51(5):289-94. Review. Spanish.

13.

Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS).

Asgari N, Owens T, Frøkiaer J, Stenager E, Lillevang ST, Kyvik KO.

Acta Neurol Scand. 2011 Jun;123(6):369-84. doi: 10.1111/j.1600-0404.2010.01416.x. Epub 2010 Sep 29. Review.

PMID:
20880299
14.

Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.

Hinson SR, Roemer SF, Lucchinetti CF, Fryer JP, Kryzer TJ, Chamberlain JL, Howe CL, Pittock SJ, Lennon VA.

J Exp Med. 2008 Oct 27;205(11):2473-81. doi: 10.1084/jem.20081241. Epub 2008 Oct 6.

15.

Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.

Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.

Arch Neurol. 2009 Sep;66(9):1164-7. doi: 10.1001/archneurol.2009.188.

PMID:
19752309
16.

[Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].

Misu T, Fujihara K, Itoyama Y.

Brain Nerve. 2008 May;60(5):527-37. Review. Japanese.

PMID:
18516975
17.

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.

Brain. 2007 May;130(Pt 5):1194-205. Epub 2007 Feb 4.

18.

Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody marker.

Weinshenker BG, Wingerchuk DM.

Curr Top Microbiol Immunol. 2008;318:343-56. Review.

PMID:
18219825
19.

Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.

Nicchia GP, Mastrototaro M, Rossi A, Pisani F, Tortorella C, Ruggieri M, Lia A, Trojano M, Frigeri A, Svelto M.

Glia. 2009 Oct;57(13):1363-73. doi: 10.1002/glia.20855.

PMID:
19229993
20.

Neuromyelitis optica.

Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG.

Curr Opin Neurol. 2007 Jun;20(3):255-60. Review.

PMID:
17495617
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk